Ingested fat and satiety

Physiology and Behavior

Volumn 81, Issue 2, 2004, Pages 275-287

  Tso, Patrick ^a   Liu, Min ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein A IV; Food intake; Hypothalamus; Intestine; Lipid; Obesity; PPY

Indexed keywords

ANTISERUM; APOLIPOPROTEIN A4; CHYLOMICRON; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; PEPTIDE YY;

BLOOD LEVEL; BODY WEIGHT; CIRCADIAN RHYTHM; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG SYNTHESIS; ENERGY EXPENDITURE; FAT INTAKE; FOOD DEPRIVATION; FOOD INTAKE; HUMAN; HYPOTHALAMUS; ILEUM; INTESTINE; INTESTINE SECRETION; JEJUNUM; LIPID ABSORPTION; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY;

EID: 2442643782     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2004.02.024     Document Type: Article

References (100)

1. Swaney J.B., Braithwaite F., Eder H.A. Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry. 16:1977;271-278
2. Fukagawa K., Gou H.M., Wolf R., Tso P. Circadian rhythm of serum and lymph apolipoprotein AIV in ad libitum-fed and fasted rats. Am. J. Physiol. 267:1994;R1385-R1390
3. Wu A.L., Windmueller H.G. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J. Biol. Chem. 254:1979;7316-7322
4. Apfelbaum T.F., Davidson N.O., Glickman R.M. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am. J. Physiol. 252:1987;G662-G666
5. Hayashi H., Nutting D.F., Fujimoto K., Cardelli J.A., Black D., Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31:1990;1613-1625
6. Kalogeris T.J., Fukagawa K., Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J. Lipid Res. 35:1994;1141-1151
7. Fujimoto K., Cardelli J.A., Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. 262:1992;G1002-G1006
8. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am. J. Physiol. 270:1996;G49-G53
9. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats. Gastroenterology. 109:1995;1583-1588
10. Okumura T., Taylor I.L., Fukagawa K., Tso P., Pappas T.N. Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat. Brain Res. 673:1995;153-156
11. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats. Gastroenterology. 107:1994;1861-1864
12. Glatzle J., Kalogeris T.J., Zittel T.T., Guerrini S., Tso P., Raybould H.E. Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G86-G91
13. Pedersen-Bjergaard U., Host U., Kelbaek H., Schifter S., Rehfeld J.F., Faber J., et al. Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scand. J. Clin. Lab. Invest. 56:1996;497-503
14. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:2002;650-654
15. Hamosh M. The role of lingual lipase in neonatal fat digestion. K Elliot J.W. Development of mammalian absorptive process Ciba Foundation Symposium 70. 1979;69-98 Excerpta Medica, Amsterdam
16. Borgstrom B. Fat digestion and absorption. Biomembranes. 4B:1974;555-620
17. Northfield T.C., Hofmann A.F. Biliary lipid output during three meals and an overnight fast: I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut. 16:1975;1-11
18. Carriere F., Barrowman J.A., Verger R., Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology. 105:1993;876-888
19. Liao T.H., Hamosh P., Hamosh M. Fat digestion by lingual lipase: mechanism of lipolysis in the stomach and upper small intestine. Pediatr. Res. 18:1984;402-409
20. Paltauf F., Esfandi F., Holasek A. Stereospecificity of lipases. Enzymic hydrolysis of enantiomeric alkyl diacylglycerols by lipoprotein lipase, lingual lipase and pancreatic lipase. FEBS Lett. 40:1974;119-123
21. Roberts I.M., Montgomery R.K., Carey M.C. Rat lingual lipase: partial purification, hydrolytic properties, and comparison with pancreatic lipase. Am. J. Physiol. 247:1984;G385-G393
22. Senior J.R. Intestinal absorption of fats. J. Lipid Res. 5:1964;495-521
23. Brockerhoff H. Substrate specificity of pancreatic lipase. Biochim. Biophys. Acta. 159:1968;296-303
24. Mattson F., Beck L. The specificity of pancreatic lipase on the primary hydroxyl groups of glycerides. J. Biol. Chem. 219:1956;735-740
25. Solomon T.E. Control of exocrine pancreatic secretion. Johnson L.R. Physiology of the gastrointestinal tract. 1994;1173-1207 Raven Press, New York
26. Rosenzweig S.A., Miller L.J., Jamieson J.D. Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study. J. Cell Biol. 96:1983;1288-1297
27. Hofmann A., Borgstrom B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed. Proc. 21:1962;43-50
28. Hofmann A., Borgstrom B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J. Clin. Invest. 43:1964;247-257
29. Stremmel W., Strohmeyer G., Borchard F., Kochwa S., Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 82:1985;4-8
30. Stremmel W. Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J. Clin. Invest. 82:1988;2001-2010
31. Lundgren S., Carling T., Hjalm G., Juhlin C., Rastad J., Pihlgren U., et al. Tissue distribution of human gp330/megalin, a putative Ca(2+)-sensing protein. J. Histochem. Cytochem. 45:1997;383-392
32. Abumrad N., Coburn C., Ibrahimi A. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim. Biophys. Acta. 1441:1999;4-13
33. Murata M., Peranen J., Schreiner R., Wieland F., Kurzchalia T.V., Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10339-10343
34. Stahl A., Hirsch D.J., Gimeno R.E., Punreddy S., Ge P., Watson N., et al. Identification of the major intestinal fatty acid transport protein. Mol. Cell. 4:1999;299-308
35. Johnston J.M., Rao G.A., Lowe P.A. The separation of the alpha-glycerophosphate and monoglyceride pathways in the intestinal biosynthesis of triglycerides. Biochim. Biophys. Acta. 137:1967;578-580
36. Nilsson A. Intestinal absorption of lecithin and lysolecithin by lymph fistula rats. Biochim. Biophys. Acta. 152:1968;379-390
37. Field F.J., Cooper A.D., Erickson S.K. Regulation of rabbit intestinal acyl coenzyme A-cholesterol acyltransferase in vivo and in vitro. Gastroenterology. 83:1982;873-880
38. Hayashi H., Fujimoto K., Cardelli J.A., Nutting D.F., Bergstedt S., Tso P. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am. J. Physiol. 259:1990;G709-G719
39. Davidson N.O., Kollmer M.E., Glickman R.M. Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J. Lipid Res. 27:1986;30-39
40. DeLamatre J.G., Roheim P.S. The response of apolipoprotein A-IV to cholesterol feeding in rats. Biochim. Biophys. Acta. 751:1983;210-217
41. Krause B.R., Sloop C.H., Castle C.K., Roheim P.S. Mesenteric lymph apolipoproteins in control and ethinyl estradiol-treated rats: a model for studying apolipoproteins of intestinal origin. J. Lipid Res. 22:1981;610-619
42. Kalogeris T.J., Holden V.R., Tso P. Stimulation of jejunal synthesis of apolipoprotein A-IV by ileal lipid infusion is blocked by vagotomy. Am. J. Physiol. 277:1999;G1081-G1087
43. Kalogeris T.J., Tsuchiya T., Fukagawa K., Wolf R., Tso P. Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion. Am. J. Physiol. 270:1996;G277-G286
44. Gonzalez-Vallina R., Wang H., Zhan R., Berschneider H.M., Lee R.M., Davidson N.O., et al. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am. J. Physiol. 271:1996;G249-G259
45. Doi T., Liu M., Seeley R.J., Woods S.C., Tso P. Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:2001;R753-R759
46. Collins S., Surwit R.S. Pharmacologic manipulation of ob expression in a dietary model of obesity. J. Biol. Chem. 271:1996;9437-9440
47. Frederich R.C., Hamann A., Anderson S., Lollmann B., Lowell B.B., Flier J.S. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1:1995;1311-1314
48. Morton N.M., Emilsson V., Liu Y.L., Cawthorne M.A. Leptin action in intestinal cells. J. Biol. Chem. 273:1998;26194-26201
49. Weinberg R.B., Dantzker C., Patton C.S. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology. 98:1990;17-24
50. Verges B.L., Lagrost L., Vaillant G., Petit J.M., Cohen M., Gambert P., et al. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. Diabetes. 46:1997;125-132
51. Lin H.C., Doty J.E., Reedy T.J., Meyer J.H. Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient. Am. J. Physiol. 259:1990;G1031-G1036
52. MacFarlane A., Kinsman R., Read N., Bloom S.R. The ileal brake: ileal fat slows small bowel transit and gastric emptying in man. Gut. 24:1983;A471-A472
53. Spiller R.C., Trotman I.F., Higgins B.E., Ghatei M.A., Grimble G.K., Lee Y.C., et al. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut. 25:1984;365-374
54. Harper A.A., Hood A.J., Mushens J., Smy J.R. Inhibition of external pancreatic secretion by intracolonic and intraileal infusions in the cat. J. Physiol. 292:1979;445-454
55. Meyer J.H., Elashoff J.D., Doty J.E., Gu Y.G. Disproportionate ileal digestion on canine food consumption. A possible model for satiety in pancreatic insufficiency. Dig. Dis. Sci. 39:1994;1014-1024
56. Welch I., Saunders K., Read N.W. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers. Gastroenterology. 89:1985;1293-1297
57. Aponte G.W., Park K., Hess R., Garcia R., Taylor I.L. Meal-induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat. FASEB J. 3:1989;1949-1955
58. Jin H., Cai L., Lee K., Chang T.M., Li P., Wagner D., et al. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology. 105:1993;208-215
59. Pappas T.N., Debas H.T., Chang A.M., Taylor I.L. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology. 91:1986;1386-1389
60. Pappas T.N., Debas H.T., Taylor I.L. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J. Clin. Invest. 77:1986;49-53
61. Rodriguez M.D., Kalogeris T.J., Wang X.L., Wolf R., Tso P. Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am. J. Physiol. 272:1997;R1170-R1177
62. Larhammar D., Soderberg C., Blomgvist A.G. Evolution of the neuropeptide Y family of peptides. Colmers W., Wahlestadt C. The biology of neuropeptide Y and related peptides. 1993;1-41 Humana Press, Totoa (NJ)
63. Adrian T.E., Bacarese-Hamilton A.J., Smith H.A., Chohan P., Manolas K.J., Bloom S.R. Distribution and postprandial release of porcine peptide YY. J. Endocrinol. 113:1987;11-14
64. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. U. S. A. 79:1982;2514-2518
65. Savage A.P., Adrian T.E., Carolan G., Chatterjee V.K., Bloom S.R. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 28:1987;166-170
66. Kalogeris T.J., Painter R.G. Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R1155-R1161
67. Covasa M., Grahn J., Ritter R.C. High fat maintenance diet attenuates hindbrain neuronal response to CCK. Regul. Pept. 86:2000;83-88
68. Covasa M., Grahn J., Ritter R.C. Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet. Auton. Neurosci. 84:2000;8-18
69. Covasa M., Ritter R.C. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R166-R170
70. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides. 19:1998;1407-1415
71. Bray G.A., Popkin B.M. Dietary fat intake does affect obesity. Am. J. Clin. Nutr. 68:1998;1157-1173
72. Hill J.O., Lin D., Yakubu F., Peters J.C. Development of dietary obesity in rats: influence of amount and composition of dietary fat. Int. J. Obes. Relat. Metab. Disord. 16:1992;321-333
73. Warwick Z.S., Bowen K.J., Synowski S.J. Learned suppression of intake based on anticipated calories: cross-nutrient comparisons. Physiol. Behav. 62:1997;1319-1324
74. West D.B., York B. Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am. J. Clin. Nutr. 67:1998;505S-512S
75. Woods S.C., Seeley R.J., Porte D. Jr., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383
76. Fujimoto K., Fukagawa K., Sakata T., Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1993;1830-1833
77. Elshourbagy N.A., Walker D.W., Paik Y.K., Boguski M.S., Freeman M., Gordon J.I., et al. Structure and expression of the human apolipoprotein A-IV gene. J. Biol. Chem. 262:1987;7973-7981
78. Voigt J.P., Huston J.P., Voits M., Fink H. Effects of cholecystokinin octapeptide (CCK-8) on food intake in adult and aged rats under different feeding conditions. Peptides. 17:1996;1313-1315
79. Liu M., Doi T., Shen L., Woods S.C., Seeley R.J., Zheng S., et al. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:2001;R1382-R1387
80. Liu M., Shen L., Doi T., Woods S.C., Seeley R.J., Tso P. Neuropeptide Y and lipid increase apolipoprotein AIV gene expression in rat hypothalamus. Brain Res. 971:2003;232-238
81. Sergeyev V., Broberger C., Gorbatyuk O., Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. NeuroReport. 11:2000;117-121
82. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:1998;293-298
83. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660
84. Adrian T.E., Allen J.M., Bloom S.R., Ghatei M.A., Rossor M.N., Roberts G.W., et al. Neuropeptide Y distribution in human brain. Nature. 306:1983;584-586
85. Allen Y.S., Adrian T.E., Allen J.M., Tatemoto K., Crow T.J., Bloom S.R., et al. Neuropeptide Y distribution in the rat brain. Science. 221:1983;877-879
86. Gehlert D.R. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides. 33:1999;329-338
87. Fujimoto K., Machidori H., Iwakiri R., Yamamoto K., Fujisaki J., Sakata T., et al. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res. 608:1993;233-237
88. Fukagawa K., Knight D.S., Hamilton K.A., Tso P. Immunoreactivity for apolipoprotein A-IV in tanycytes and astrocytes of rat brain. Neurosci. Lett. 199:1995;17-20
89. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432
90. Attia N., Touzani A., Lahrichi M., Balafrej A., Kabbaj O., Girard-Globa A. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus. Diabet. Med. 14:1997;242-247
91. Black D.D., Ellinas H. Apolipoprotein synthesis in newborn piglet intestinal explants. Pediatr. Res. 32:1992;553-558
92. Tatemoto K., Mutt V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature. 285:1980;417-418
93. Anini Y., Fu-Cheng X., Cuber J.C., Kervran A., Chariot J., Roz C. Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers. Arch. 438:1999;299-306
94. Plaisancie P., Dumoulin V., Chayvialle J.A., Cuber J.C. Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. J. Endocrinol. 151:1996;421-429
95. Vu M.K., Verkijk M., Muller E.S., Biemond I., Lamers C.B., Masclee A.A. Medium chain triglycerides activate distal but not proximal gut hormones. Clin. Nutr. 18:1999;359-363
96. Aponte G.W., Fink A.S., Meyer J.H., Tatemoto K., Taylor I.L. Regional distribution and release of peptide YY with fatty acids of different chain length. Am. J. Physiol. 249:1985;G745-G750
97. Wettergren A., Petersen H., Orskov C., Christiansen J., Sheikh S.P., Holst J.J. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand. J. Gastroenterol. 29:1994;501-505
98. Lloyd K.C. Gut hormones in gastric function. Baillieres Clin. Endocrinol. Metab. 8:1994;111-136
99. Kalogeris T.J., Qin X., Chey W.Y., Tso P. PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression. Am. J. Physiol. 275:1998;G668-G674
100. Weinberg R.B., Spector M.S. The self-association of human apolipoprotein A-IV. Evidence for an in vivo circulating dimeric form. J. Biol. Chem. 260:1985;14279-14286